A preview of this full-text is provided by Wiley.
Content available from Applied Organometallic Chemistry
This content is subject to copyright. Terms and conditions apply.
Applied Organometallic Chemistry, 2024; 38:e7726
https://doi.org/10.1002/aoc.7726
1 of 11
Applied Organometallic Chemistry
Royal Jelly–Mediated Silver Nanoparticles Show Promising
Anticancer Effect on HeLa and A549 Cells Through
Modulation of the VEGFa/PI3K/Akt/MMP- 2 Pathway
MeriKocharyan1 | SyuzanMarutyan1 | EditaNadiryan1 | MikayelGinovyan1 | HayarpiJavrushyan1 | SedaMarutyan2 |
NikolayAvtandilyan1
1Research Institute of Biology, Yerevan State University, Yerevan, Armenia | 2Department of Biochemistry, Microbiology, and Biotechnology, Yerevan State
University, Yerevan, A rmenia
Correspondence: Nikolay Avtandilyan (nv.avtandilyan@ysu.am)
Received: 23 March 202 4 | Revised: 19 July 2024 | Accepted: 14 August 2024
Funding: This work was supported by the Science Committee of MESCS RA through research projects numbered 21T- 1F283, 21T- 1F300, and
23LCG- 1F010.
Keywords: cytotoxicity | oxidative stress | PI3K/AKT pathway | royal jelly | silver nanoparticles
ABSTR ACT
In recent years, nanotechnology has revolutionized various sectors, particularly in nanomedicine, where nanomaterials are used
for diagnosis, monitoring, control, prevention, and treatment. Among these, silver nanoparticles (AgNPs) stand out due to their
remarkable antimicrobial a nd cytotoxic properties. Traditional chemical synthesis of AgN Ps poses significant environmental and
health risks. This study introduces a novel, eco- friendly synthesis method using royal jelly (RJ), a nutrient- rich secretion from
honeybees, to produce AgNPs with potent anticancer effects. Our research provides a detailed investigation into RJ- mediated
AgNPs’ modulation of the VEGFa/PI3K/Akt/MMP- 2 pathway in HeLa and A549 cancer cell lines. AgNP characterization was
performed by applying UV–Vis spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM) in
combination with selected area electron diffraction (SAED). Cell signaling system components were determined by ELISA anal-
ysis. The cells were subjected to staining with hematoxylin and eosin to visualize the treatment’s effects. This study focuses on
the green synthesis of AgNPs using RJ and its bioactivity against cancer cells. It provides a detailed characterization of the na-
noparticles and examines their effects on cancer cells, specifically HeLa cervical cancer and A549 lung cancer cell lines. Green
synthesized AgNPs demonstrate significant cytotoxic effects against HeLa and A549 cancer cell lines. The underlying molecular
mechanisms contributing to their anticancer activity were elucidated. Our findings revealed a significant decrease in arginase
activity upon exposure to AgNPs, accompanied by reductions in PI3K and phosphorylated and total Akt levels, indicative of
pathway inhibition. Additionally, RJAgNP demonstrated a capacity to reduce nitric oxide levels and suppress angiogenesis-
related factors like VEGF and MMP- 2 and inflammation- related factors like TNF- α and COX- 2, thus impeding angiogenesis and
metastasis. Moreover, our results shed light on the involvement of reactive oxygen intermediates (ROIs) in mediating apoptotic
pathways, as evidenced by the increase in malondialdehyde (MDA) concentration and the corresponding decrease in Akt levels,
ultimately promoting death in cancer cells. Our study contributes significantly to the field of nanomedicine and cancer therapy
© 2024 J ohn Wiley & Sons, Lt d.
Abbreviations: AKT, protein k inase B; AgN P, silver nanop articles; COX- 2 , cyclooxygena se- 2; DLS , dynamic light s cattering; DM EM, Dulbecc o’s Modified Eag le Medium; DMSO, di methyl
sulfox ide; ELISA, en zyme- linked immu nosorbent assay ; FU, fluorourac il; GNPs, gre en synthesis na noparticles; H& E, hematoxyli n and eosin; MDA, m alondialdehyde; MM P- 2, matri x
metallopr oteinase- 2; mTOR, mam malian targe t of rapamycin; MT T, 3- (4,5 - dimeth ylthiazol- 2 - yl)- 2 ,5- d iphenyltetrazoliu m bromide; NF- κB, nuclear f actor kappa- light- chain- enhancer of
activat ed B cells; NO, nitr ic oxide; PBS, phosph ate buffered sa line; PDI, protein d isulfide isomer ase; PI3K, phosph oinositide 3- k inase; RJ, r oyal jelly; R JAgNP, silver nanopa rticles synthe sized in
the presenc e of royal jelly; ROS , reactive ox ygen species; SA ED, selected are a (electron) di ffraction; T EM, transmi ssion electron micr oscopy; TNF a lpha, tumor necro sis factor- a lpha; VEGF,
vascular endothelial growth factor.
RESEARCH ARTICLE